FDA Inspection 1151497 — Philips Respironics, Inc.

Philips Respironics, Inc. — FEI 2518422

The FDA completed an inspection of Philips Respironics, Inc. on September 10, 2021 in Murrysville, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 10, 2021
Fiscal Year
2021
Product Type
Devices
Project Area
Compliance: Devices
Location
Murrysville, PA (United States)

Citations

IDCFRDescription
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures
317221 CFR 820.198(c)Investigation of device failures